Name | Title | Contact Details |
---|---|---|
Jennifer Harvey |
VP of Human Resources | Profile |
Eron Davis |
Global Talent Director | Profile |
John Leite |
Chief Commercial Officer, CLIA | Profile |
Jonathan Wygant |
Chief Accounting Officer | Profile |
Samantha Gooden |
Associate Director, Laboratory Operations - Richmond | Profile |
Oragenics is a publicly-traded biopharmaceutical company with a pipeline of unique proprietary technologies.
THEON is a patient-focused drug discovery company developing small molecule correctors of RNA pathobiology.
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome – vast stretches of uncharted genetic material that have long been dismissed as “junk DNA.”
Medarray is a Ann Arbor, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
At InterveXion we develop novel products for the treatment of addiction disorders. Since our founding in 2004, our team has been dedicated to providing therapeutic options for patients suffering from the debilitating effects of addiction. We occupy office and laboratory space in the BioVentures Building on the campus of the University of Arkansas for Medical Sciences (UAMS), from whom we licensed our lead technology.